GGI
RMD icon

Godsey & Gibb Inc’s ResMed RMD Stock Holding History

Godsey & Gibb Inc’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.68K Buy
+24
New +$4.97K ﹤0.01% 317

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Godsey & Gibb Inc's RMD Position: Q2 2026 in Review

Godsey & Gibb Inc opened a new position in ResMed (RMD) in Q2 2026: 24 shares worth $4.68K. The stake represents ﹤0.01% of the portfolio and ranks #317 among its holdings.

891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Godsey & Gibb Inc held 24 shares of ResMed worth $4.68K as of Q2 2026.
  • ResMed was a new Godsey & Gibb Inc position in Q2 2026.
  • ResMed made up ﹤0.01% of Godsey & Gibb Inc's portfolio in Q2 2026, its #317 holding.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Godsey & Gibb Inc's 13F filing for Q2 2026, filed 13 Jul 2026.